PUBLISHER: Acute Market Reports | PRODUCT CODE: 1313720
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1313720
The global Zygomatic and pterygoid implants market was valued at more than US$ 302.4 million in 2021 and is expected to reach over US$ 513.04 million by 2030, expanding at a CAGR of 6.0% from 2022 to 2030.
Zygomatic and pterygoid implants are long facial implants used in patients in case of insufficient quality and quantity of bone for regular implant anchorage. In such cases, cheekbones are used for anchorage with longer implants. In patients with severe maxillary resorption, grafting procedures are time consuming, thus paving way for anchoring the implant on the zygomatic bone. Zygomatic implants offer immediate loading protocol for graft-free procedures. This not just reduces the procedure time, but also improves patient satisfaction with enhanced treatment outcome. Many hospitals have reported a success rate above 98%. Zygomatic implants allow higher level of primary stability in patients with severe bone loss with permanent prosthesis implanted immediately after surgery. Use of zygomatic and pterygoid implants also allow immediate implantation thus avoiding the 9 to 12 month waiting period and multiple surgeries needed for grafting. Apart from immediate functioning, zygomatic implants also gave other benefits such as lesser clinic visits and follow-ups, less invasion in procedures and so on. Zygomatic implants have become a clear implant of choice for several orthodontic surgeons. With the onset of COVID-19 infection that was declared as pandemic by the WHO, many hospitals were shut down for non emergency procedures. This was required to manage limited resources in emergency surgeries and treatment of COVID-19. This had a significant on the revenues and growth of the market.
Based on the implant length, the global zygomatic and pterygoid implants market is categorized into upto 30 mm, 31-40 mm, 41-50 mm and above 50 mm. of these, 31-40 mm implants experience the highest demand in the global market. These devices have a 45 degree angulated head to make up with the angulation with the maxilla and zygoma. At the maxilla, the angulated implant offers the benefit to screw any form of abutment.
Based on the applications, zygomatic and pterygoid implants are in highest demand in treatment of severe atrophy of maxillary bone. The severe edentulous atrophy of maxilla due to alveolar bone peneumatisation and resorption of the maxillary sinus. This represents a severe challenge for implant rehabilitation. Insertion of implant through the palate with minimally invasive method allows increase in the bone volume without the use of bone harvesting. For bypassing such occurrence, different surgical methods are proposed such as guided bone regeneration, implant insertion in maxillary tuberosity and zygomatic and pterygoid implants. Recently pterygoid and zygomatic implant solution has gained popularity among the patients as these procedures offer better treatment outcome while reducing total procedure cost, with augmented healing and reduced treatment period. Zygomatic and pterygoid implantation avoid big surgical field and flap, thus reduced morbidity of treatment.
In terms of usage areas, the global zygomatic and pterygoid implants market is segmented for dental and orthodontic clinics, and hospitals. Dental and orthodontic clinics dominate the global market due to high patient footfall. Factors such as higher availability of better skills, rapid patient handling and lesser costs support the prominent position of this segment. On the other hand, hospitals segment shall be picking rapid pace during the forecast period due to improving reimbursement scenario.
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa cumulatively make the global zygomatic and pterygoid implants market. Europe due to the better availability of skilled surgeons, rapid adoption of novel implants and surgical techniques and better awareness is the largest market for zygomatic and pterygoid implants. Asia Pacific, on the other hand, is rapidly advancing to capture larger market shares. Proliferating dental tourism, moderate costs of dental procedures and rapidly evolving healthcare infrastructure are the key catalysts facilitating the growth of the global zygomatic and pterygoid implants market.
This report also includes company profiles section that gives insights on the company overview, product portfolio, financial information and key developments of major market players. The major players profiled in this report include Nobel Biocare, IDC Implant & Dental Company, Straumann Holding AG, Noris Medical, OsseoSource, S.I.N. Implant System, Southern Implants (Pty) Ltd., B&B Dental Implant Company, and Bioline Dental Implants.
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofZygomatic and Pterygoid Implants market are as follows:
Micro and macro environment factors that are currently influencing the Zygomatic and Pterygoid Implants market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
FIG. 10Market Positioning of Key Zygomatic and Pterygoid Implants Market Players, 2022
FIG. 11Global Zygomatic and Pterygoid Implants Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
FIG. 12Porters Five Force Model - Current, Midterm and Long Term Perspective
FIG. 13See Saw Analysis
FIG. 14PETEL Analysis
FIG. 15Key Buying Criteria: Current and Long-Term Perspective
FIG. 16Global Zygomatic and Pterygoid Implants Market, Scenario Analysis, 2021 to 2031 (US$ Million)
FIG. 17Heptalysis Analysis: Global Zygomatic and Pterygoid Implants Market
FIG. 18Five Whys Analysis